首页|反复药物性肝损伤患者的临床特征及转归分析

反复药物性肝损伤患者的临床特征及转归分析

扫码查看
目的 分析不同药物所致反复药物性肝损伤(DILI)患者的临床特征及转归。方法 收集2015年1月至2022年12月本院住院并确诊两次及以上的反复DILI患者93例,比较两次DILI的基线特征、肝损药物种类及相关基础疾病、检验结果、肝穿结果、激素治疗及临床结局等。结果 93例反复DILI患者中以女性居多(71%),两次发病平均间隔时间25。5个月,均以1级肝损伤及肝细胞损伤型为主,再次DILI潜伏期时间(26。7个月)明显短于首次DILI(38。4个月),差异存在统计学意义(P<0。05)。在两次DILI中肝损药物均以单用我国传统中草药(TCM)为主(51。61%VS。36。56%),合并用药中以TCM联合解热镇痛药物及膳食补充剂为主(5。38%VS。3。23%)。TCM中以骨科用途居多,其次为保健用途。首次DILI时TBIL、DBIL、ALP、GGT、TBA、TG、AFP均高于再次DILI,差异有统计学意义(P<0。01)。反复DILI过程中52。63%患者肝穿病理提示纤维化评分<2分,其中2例两次肝穿病理均诊断单纯性DILI患者,第二次纤维化较第一次轻;肝穿病理中存在DILI诱导的自身免疫样肝炎或已经进展至AIH共8例,其炎症程度及纤维化评分均≥2。20例患者在反复DILI发生过程中使用小剂量短程激素治疗。对比前后两次DILI的肝纤维化四项及肝脏瞬时弹性成像彩超结果,差异无统计学意义(P>0。05)。结论 反复DILI患者以轻度肝炎为主,大多数转归良好;但需警惕部分患者慢性持续暴露于肝损药物,尤其是成分相对复杂的中草药,可能诱导自身免疫样DILI发生,或进展至自身免疫性肝炎。
Objective To analyze the clinical data and outcomes of recurrent drug-induced liver injury(DILI)by different drugs.Methods A total of 93 patients with recurrent DILI who were admitted to our hospital and diagnosed twice or more from January 2015 to December 2022 were collected and statistically analyzed by T-test,Wilcoxon rank sum test,and Chi-squared Test method.Baseline characteristics of DILI,types of liver injury drugs and related underlying diseases,test results,liver pathology results,hormone therapy,and clinical outcomes were compared.Results The majority of 93 patients with recurrent DILI were female,and the average interval between recurrent DILI was 25.5 months.Grade 1 liver injury and hepatocyte injury were predominant in patients with recurrent DILI.The incubation time of the second DILI was 26.7 months,which was significantly shorter than that of the first DILI(38.4 months),and had statistical significance(P<0.05).In the recurrent DILI cases,Traditional Chinese medicine was the main drug used alone(51.61%VS.36.56%),and TCM combined with antipyretic and analgesic drugs and dietary supplements were the main drugs used in combination(5.38%VS.3.23%).TCM was mainly used for orthopedic purposes,followed by health purposes.TBIL,DBIL,ALP,GGT,TBA,TG,and AFP in the first DILI were higher than those in the second DILI,the Z values were respectively-4.835,-4.640,-2.699,-2.861,-2.871,-3.667,-3.311,with significant statistical significance(P<0.01).In the course of recurrent DILI,52.63%of patients'liver perforation pathology indicated that the fibrosis score was less than 2 points.Among them,two patients were diagnosed with simple DILI after two liver perforations,and fibrosis the second time was lighter than that of the first time.There were 8 cases(20.05%)with AIH-like DILI or advanced AIH,and the degree of inflammation and fibrosis score were both≥2.Twenty patients(21.5%)were treated with a short course of low-dose hormone therapy during recurrent DILI.There was no significant difference in the results of liver fibrosis and instantaneous elastic imaging color ultrasound compared to recurrent DILI(P>0.05).Conclusion Mild hepatitis was predominant in 93 patients with recurrent DILI,and most outcomes were good.However,it remains to be warned that some patients'continuous and chronic exposure to hepato-damaging drugs,especially Chinese herbal medicines with relatively complex components,may induce autoimmunity like DILI or AIH.

Recurrent drug-induced liver injuryTraditional Chinese medicineClinical characteristicsLiver histopathologyOutcome analysis

刘永萍、吴晓瑛、余楷、孟樱、郑燕、黄伟、赵宇舸、张仙土、刘雁

展开 >

310000 浙江中医院大学附属杭州西溪医院

反复药物性肝损伤 传统中草药 临床特征 肝组织病理 临床转归

浙江省医药卫生科技计划项目杭州市医药卫生科技项目杭州市生物医药和健康产业发展扶持科技专项

2024KYZ12A202202282022WJC288

2024

浙江临床医学
浙江中医药大学 浙江省科普作家协会医学卫生委员会

浙江临床医学

影响因子:0.52
ISSN:1008-7664
年,卷(期):2024.26(8)